Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The primordial differentiation of tumor-specific memory CD8+ T cells as bona fide responders to PD-1/PD-L1 blockade in draining lymph nodes
Qizhao Huang, Xia Wu, Zhiming Wang, et al.
Cell (2022) Vol. 185, Iss. 22, pp. 4049-4066.e25
Open Access | Times Cited: 248

Showing 26-50 of 248 citing articles:

Mitochondria-ER contact mediated by MFN2-SERCA2 interaction supports CD8 + T cell metabolic fitness and function in tumors
Jiefeng Yang, Xudong Xing, Li Luo, et al.
Science Immunology (2023) Vol. 8, Iss. 87
Closed Access | Times Cited: 38
Selective Mediastinal Lymph Node Dissection Strategy for Clinical T1N0 Invasive Lung Cancer: A Prospective, Multicenter, Clinical Trial
Yang Zhang, Chaoqiang Deng, Qiang Zheng, et al.
Journal of Thoracic Oncology (2023) Vol. 18, Iss. 7, pp. 931-939
Open Access | Times Cited: 35
Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity
Senbo Liu, Wenkang Wang, Shengyun Hu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 10
Open Access | Times Cited: 35
Defining and using immune archetypes to classify and treat cancer
Alexis J. Combes, Bushra Samad, Matthew F. Krummel
Nature reviews. Cancer (2023) Vol. 23, Iss. 7, pp. 491-505
Closed Access | Times Cited: 34
Regulation of CD8+ T memory and exhaustion by the mTOR signals
Yao Chen, Ziyang Xu, Hongxiang Sun, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 9, pp. 1023-1039
Open Access | Times Cited: 26
Strategies to reinvigorate exhausted CD8+ T cells in tumor microenvironment
Qianting Guan, Meiwen Han, Qinghao Guo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24
CCL19+ dendritic cells potentiate clinical benefit of anti-PD-(L)1 immunotherapy in triple-negative breast cancer
Song‐Yang Wu, Si-Wei Zhang, Ding Ma, et al.
Med (2023) Vol. 4, Iss. 6, pp. 373-393.e8
Open Access | Times Cited: 23
Abrine, an IDO1 inhibitor, suppresses the immune escape and enhances the immunotherapy of anti-PD-1 antibody in hepatocellular carcinoma
Xiaowei Liang, Hongwei Gao, Jian Xiao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
ITPRIPL1 binds CD3ε to impede T cell activation and enable tumor immune evasion
Shouyan Deng, Yibo Zhang, Huanbin Wang, et al.
Cell (2024) Vol. 187, Iss. 9, pp. 2305-2323.e33
Closed Access | Times Cited: 15
Immunometabolism of CD8+ T cell differentiation in cancer
Hao Shi, Sidi Chen, Hongbo Chi
Trends in cancer (2024) Vol. 10, Iss. 7, pp. 610-626
Closed Access | Times Cited: 15
Lymphatic vessels in the age of cancer immunotherapy
Triantafyllia Karakousi, Tenny Mudianto, Amanda W. Lund
Nature reviews. Cancer (2024) Vol. 24, Iss. 6, pp. 363-381
Closed Access | Times Cited: 14
Seizing the fate of lymph nodes in immunotherapy: To preserve or not?
Zhenyu Xu, Zi‐Zhan Li, Lei‐Ming Cao, et al.
Cancer Letters (2024) Vol. 588, pp. 216740-216740
Closed Access | Times Cited: 13
Targeting novel regulated cell death: Ferroptosis, pyroptosis and necroptosis in anti‐PD‐1/PD‐L1 cancer immunotherapy
Li Yu, Ke Huang, Yixiang Liao, et al.
Cell Proliferation (2024) Vol. 57, Iss. 8
Open Access | Times Cited: 13
An oncolytic virus delivering tumor-irrelevant bystander T cell epitopes induces anti-tumor immunity and potentiates cancer immunotherapy
Xiangyu Chen, Jingxin Zhao, Shuai Yue, et al.
Nature Cancer (2024) Vol. 5, Iss. 7, pp. 1063-1081
Open Access | Times Cited: 13
Antitumor progenitor exhausted CD8+ T cells are sustained by TCR engagement
Xin Lan, Mi Tian, Shanta Alli, et al.
Nature Immunology (2024) Vol. 25, Iss. 6, pp. 1046-1058
Closed Access | Times Cited: 13
Glycolysis inhibition induces anti-tumor central memory CD8+T cell differentiation upon combination with microwave ablation therapy
Xinyu Tang, Xinrui Mao, Peiwen Ling, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Circulating cancer-specific CD8 T cell frequency is associated with response to PD-1 blockade in Merkel cell carcinoma
Thomas H. Pulliam, Saumya Jani, Lichen Jing, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101412-101412
Open Access | Times Cited: 12
Targets of tumor microenvironment for potential drug development
Ling Zhang, Ziruoyu Wang, Kailu Liu, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 11
Salmonella-mediated methionine deprivation drives immune activation and enhances immune checkpoint blockade therapy in melanoma
Sujin Zhou, Shiwei Zhang, Kexin Zheng, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 2, pp. e008238-e008238
Open Access | Times Cited: 10
Preclinical study and phase II trial of adapting low-dose radiotherapy to immunotherapy in small cell lung cancer
Hui Wang, Zhuoran Yao, Kai Kang, et al.
Med (2024) Vol. 5, Iss. 10, pp. 1237-1254.e9
Open Access | Times Cited: 10
CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases
Yuanfang Li, Yongqiang Zheng, Jiaqian Huang, et al.
Gut (2024), pp. gutjnl-333617
Open Access | Times Cited: 10
Distinct tumor microenvironment makes anaplastic thyroid cancer more lethal but immunotherapy-sensitive than papillary thyroid cancer
Paul K. J. Han, Weidong Ye, Pengcheng Yu, et al.
JCI Insight (2024)
Open Access | Times Cited: 9
Resident memory T cells and cancer
Noah Veis Gavil, Katarina Cheng, David Masopust
Immunity (2024) Vol. 57, Iss. 8, pp. 1734-1751
Closed Access | Times Cited: 9
Expansion of tumor-reactive CD8 + T cell clonotypes occurs in the spleen in response to immune checkpoint blockade
Duncan M. Morgan, Brendan Horton, Vidit Bhandarkar, et al.
Science Immunology (2024) Vol. 9, Iss. 99
Closed Access | Times Cited: 9
Current trends in sensitizing immune checkpoint inhibitors for cancer treatment
Jing Wei, Wenke Li, Pengfei Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8

Scroll to top